Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs
The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.
The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.
Phone: 1800 678 242
Beckman Coulter Life Sciences Valita Aggregation Pure assay
Beckman Coulter Life Sciences' Valita Aggregation Pure assay is a plate-based, 96-well...
BioStatus DRAQ9 Far-Red Fluorescent Live-Cell Tracking Dye
BioStatus's DRAQ9 is a novel far-red fluorescent dye that labels membranous structures in the...
Invent Biotechnologies Minute Plasma Membrane Protein Isolation and Cell Fractionation Kit
Invent Technologies Minute kits are next-generation products for plasma membrane (PM) isolation...
